XML 19 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Income - USD ($)
12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2015
Total sales $ 23,816,735 $ 6,645,780 $ 5,852,924
Cost of Sales 15,792,458 4,334,815 3,168,303
Gross Profit 8,024,277 2,310,965 2,684,621
Operating Expenses:      
Product development costs 795,957 1,050,157 1,015,414
Selling, general and administrative expenses 4,546,383 1,933,986 1,727,021
Operating Income (Loss) 2,681,937 (673,178) (57,814)
Other (Income) and Expenses:      
Interest charges 282,648 59,386 657
Legal settlement (50,000) (2,270,567)
Other expense, net 260,529 204,755 63,906
Total Other (Income) and Expenses 493,177 (2,006,426) 64,563
Income (Loss) before Provision for Income Taxes 2,188,760 1,333,248 (122,377)
Current 86,966 31,000 (82,200)
Deferred 693,398 (3,330,600) 82,200
Total Provision for (Recovery of) Income Taxes 780,364 (3,299,600)
Net Income (Loss) $ 1,408,396 $ 4,632,848 $ (122,377)
Net Income (Loss) Per Common Share - Basic (in dollars per share) $ 0.49 $ 2.38 $ (0.07)
Net Income (Loss) Per Common Share - Diluted (in dollars per share) $ 0.46 $ 2.36 $ (0.07)
Weighted Average Shares of Common Stock Outstanding – Basic (in shares) 2,874,926 1,943,625 1,638,215
Weighted Average Shares of Common Stock Outstanding - Diluted (in shares) 3,069,077 1,960,121 1,638,215